Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Randomized Controlled Trial

Review

Retracted Publication

Research Support, N.I.H., Extramural

Multicenter Study

Publication Year

From

Quick links

Individual year

2014

2011

2010

2007

2006

2005

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for

""Tumor Necrosis Factor Decoy Receptors""[mesh_terms]

9 Results

Searching titles within these results

TNF receptor p55 and IL-8(72) and IL-8(77) isoforms: blood and urine levels in breast cancer patients.

Ninel M Berezhnaya, Yury A Grinevich, Ludmila G Yugrinova, Anna D Lon, Oksana B Belova, Svetlana Akalovich, Oksana Pashkova, Nikolai N Voitenok, Valentin P Shichkin

Journal of immunotoxicology 2010;6(4):235-42

Free Full Text

Abstract

Lack of effect of TNFalpha blockade therapy on circulating adiponectin levels in patients with autoimmune disease: results from two independent prospective studies.

Mike J L Peters, Pauline Watt, Lynne Cherry, Paul Welsh, Eric Henninger, Ben A C Dijkmans, Iain B McInnes, Michael T Nurmohamed, Naveed Sattar

Annals of the rheumatic diseases 2010;69(9):1687-90

Full Text

Abstract

Gastric and intestinal barrier impairment in tropical enteropathy and HIV: limited impact of micronutrient supplementation during a randomised controlled trial.

Paul Kelly, Tamara Shawa, Stayner Mwanamakondo, Rose Soko, Geoff Smith, G Robin Barclay, Ian R Sanderson

BMC gastroenterology 2010;10():72

Free Full Text

Abstract

Effects of tumor necrosis factor blockade on cardiovascular risk factors in psoriatic arthritis: a double-blind, placebo-controlled study.

Naveed Sattar, Philippa Crompton, Lynne Cherry, David Kane, Gordon Lowe, Iain B McInnes

Arthritis and rheumatism 2007;56(3):831-9

Full Text

Abstract

Psoriatic arthritis.

Dafna D Gladman

Dermatologic therapy 2005;17(5):350-63

Full Text

Abstract

Modulation of gut barrier function in patients with obstructive jaundice using probiotic LP299v.

Claire Jones, Stephen A Badger, Mark Regan, Barry W Clements, Tom Diamond, Rowan W Parks, Mark A Taylor

European journal of gastroenterology & hepatology 2014;25(12):1424-30

Full Text

Abstract

ROS and CHOP are critical for dibenzylideneacetone to sensitize tumor cells to TRAIL through induction of death receptors and downregulation of cell survival proteins.

Jayaraj Ravindran, Vivek R Yadav, Sahdeo Prasad, Bharat B Aggarwal

Cancer research 2011;71(2):538-49

Free Full Text

Abstract

Survivin inhibits apoptosis induced by TRAIL, and the ratio between survivin and TRAIL receptors is predictive of recurrent disease in neuroblastoma.

Takeo Azuhata, David Scott, Thomas S Griffith, Michal Miller, Anthony D Sandler

Journal of pediatric surgery 2006;41(8):1431-40

Full Text

Abstract

TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL.

Roberta Riccioni, Luca Pasquini, Gualtiero Mariani, Ernestina Saulle, Annalisa Rossini, Daniela Diverio, Elvira Pelosi, Antonella Vitale, Anna Chierichini, Michele Cedrone, Robin Foà, Francesco Lo Coco, Cesare Peschle, Ugo Testa

Haematologica 2007;90(5):612-24

Full Text

Abstract

Results: 1 – 9 / 9

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Tumor Necrosis Factor Decoy Receptors""[mesh_terms]

TNF receptor p55 and IL-8(72) and IL-8(77) isoforms: blood and urine levels in breast cancer patients.

Lack of effect of TNFalpha blockade therapy on circulating adiponectin levels in patients with autoimmune disease: results from two independent prospective studies.

Gastric and intestinal barrier impairment in tropical enteropathy and HIV: limited impact of micronutrient supplementation during a randomised controlled trial.

Effects of tumor necrosis factor blockade on cardiovascular risk factors in psoriatic arthritis: a double-blind, placebo-controlled study.

Psoriatic arthritis.

Modulation of gut barrier function in patients with obstructive jaundice using probiotic LP299v.

ROS and CHOP are critical for dibenzylideneacetone to sensitize tumor cells to TRAIL through induction of death receptors and downregulation of cell survival proteins.

Survivin inhibits apoptosis induced by TRAIL, and the ratio between survivin and TRAIL receptors is predictive of recurrent disease in neuroblastoma.

TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL.

Results for

""Tumor Necrosis Factor Decoy Receptors""[mesh_terms]